We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Is Prestige Brands (PBH) Up 0.5% Since Last Earnings Report?
Read MoreHide Full Article
A month has gone by since the last earnings report for Prestige Brands (PBH - Free Report) . Shares have added about 0.5% in that time frame, underperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Prestige Brands due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Prestige Consumer Q3 Earnings Beat Estimates, Sales Lag
Prestige Consumer came out with third-quarter fiscal 2019 results, wherein adjusted earnings beat the Zacks Consensus Estimate, while sales lagged the same. Moreover, sales declined year over year, owing to sluggish performance in North American and International segments.
Q3 Details
The company posted adjusted earnings of 73 cents per share, up 4.3% from the year-ago quarter’s 70 cents. This upside can be attributed to a solid financial status and robust free cash flow. Also, the figure surpassed the Zacks Consensus Estimate of 71 cents and marked its fourth consecutive quarter of earnings beat.
Total revenues of $241.4 million missed the Zacks Consensus Estimate of $244 million. The top line dropped 10.8% year over year. Further, organic revenues decreased 3.1% on reduced inventory. Organic revenues don’t include the impact of sale of the Household Cleaning segment and any foreign currency movements.
Gross profit came in at $139.2 million, reflecting a decline of 5.7% from the prior-year quarter’s figure. However, gross margin expanded 310 basis points (bps) to 57.7% in the fiscal third quarter, primarily driven by the divestiture of the Household Cleaning segment, change in revenue recognition accounting policies and the timing of associated costs.
Adjusted EBITDA was $85.2 million, down 7.2% year over year, owing to the household segment divestiture, packaging expenses of BC & Goody’s brands, and significant inventory reductions. Adjusted EBITDA margin expanded 140 bps to 35.3%.
Segment Performance
Following the divestiture of the Household Cleaning segment on Jul 2, 2018, Prestige Consumer is currently operating two segments — the North American OTC Healthcare and the International OTC Healthcare.
Revenues in the North American OTC Healthcare segment amounted $216.8 million, down 3.9% year over year, owing to reduced inventory at certain key retailers.
Revenues in the International OTC Healthcare segment totaled $24.6 million, down 4.3% from the year-ago quarter. The decline was attributable to unfavorable impact of foreign currency and normalization of differences in shipments and distributor orders.
Financial Updates
The company exited the quarter under review with cash and cash equivalents of $24.7 million, net long-term debt of $1,895.8 million and shareholders’ equity of $1,842.3 million. During the quarter, the company lowered its debt by $55 million, and in the nine months ending Dec 31, 2018, it reduced debt by $155 million. Net cash provided by operating activities in the quarter was $43.3 million.
Outlook
The company retained its fiscal 2019 outlook. Management continues to expect revenues of $970-$975 million, with organic revenue growth anticipated to range between flat and increase 0.5%. Further, adjusted earnings per share is still projected to be $2.75-$2.78 whose mid-point of $2.77 is slightly above the Zacks Consensus Estimate of $2.76. Moreover, gross margin for fiscal 2019 is still expected to be approximately 57%. Additionally, adjusted free cash flow is anticipated to come in at least $200 million.
Moving on, Prestige Consumer is on track with its three core strategies that resulted in solid free cash flow. This, in turn, enabled the company to lower its debt to a certain extent in the quarter. Prestige Consumer is gaining on strength in leading brands that offset the impact of inventory reductions in the quarter under review. Going ahead, the company is well-positioned for long-term growth with a strong and diversified product portfolio. Also, it is striving to maintain a strong balance sheet and cost-effective capital allocation, and return high value to shareholders.
How Have Estimates Been Moving Since Then?
Fresh estimates followed a downward path over the past two months.
VGM Scores
Currently, Prestige Brands has a subpar Growth Score of D, however its Momentum Score is doing a lot better with an A. Following the exact same course, the stock was allocated a grade of A on the value side, putting it in the top quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Prestige Brands has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why Is Prestige Brands (PBH) Up 0.5% Since Last Earnings Report?
A month has gone by since the last earnings report for Prestige Brands (PBH - Free Report) . Shares have added about 0.5% in that time frame, underperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Prestige Brands due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Prestige Consumer Q3 Earnings Beat Estimates, Sales Lag
Prestige Consumer came out with third-quarter fiscal 2019 results, wherein adjusted earnings beat the Zacks Consensus Estimate, while sales lagged the same. Moreover, sales declined year over year, owing to sluggish performance in North American and International segments.
Q3 Details
The company posted adjusted earnings of 73 cents per share, up 4.3% from the year-ago quarter’s 70 cents. This upside can be attributed to a solid financial status and robust free cash flow. Also, the figure surpassed the Zacks Consensus Estimate of 71 cents and marked its fourth consecutive quarter of earnings beat.
Total revenues of $241.4 million missed the Zacks Consensus Estimate of $244 million. The top line dropped 10.8% year over year. Further, organic revenues decreased 3.1% on reduced inventory. Organic revenues don’t include the impact of sale of the Household Cleaning segment and any foreign currency movements.
Gross profit came in at $139.2 million, reflecting a decline of 5.7% from the prior-year quarter’s figure. However, gross margin expanded 310 basis points (bps) to 57.7% in the fiscal third quarter, primarily driven by the divestiture of the Household Cleaning segment, change in revenue recognition accounting policies and the timing of associated costs.
Adjusted EBITDA was $85.2 million, down 7.2% year over year, owing to the household segment divestiture, packaging expenses of BC & Goody’s brands, and significant inventory reductions. Adjusted EBITDA margin expanded 140 bps to 35.3%.
Segment Performance
Following the divestiture of the Household Cleaning segment on Jul 2, 2018, Prestige Consumer is currently operating two segments — the North American OTC Healthcare and the International OTC Healthcare.
Revenues in the North American OTC Healthcare segment amounted $216.8 million, down 3.9% year over year, owing to reduced inventory at certain key retailers.
Revenues in the International OTC Healthcare segment totaled $24.6 million, down 4.3% from the year-ago quarter. The decline was attributable to unfavorable impact of foreign currency and normalization of differences in shipments and distributor orders.
Financial Updates
The company exited the quarter under review with cash and cash equivalents of $24.7 million, net long-term debt of $1,895.8 million and shareholders’ equity of $1,842.3 million. During the quarter, the company lowered its debt by $55 million, and in the nine months ending Dec 31, 2018, it reduced debt by $155 million. Net cash provided by operating activities in the quarter was $43.3 million.
Outlook
The company retained its fiscal 2019 outlook. Management continues to expect revenues of $970-$975 million, with organic revenue growth anticipated to range between flat and increase 0.5%. Further, adjusted earnings per share is still projected to be $2.75-$2.78 whose mid-point of $2.77 is slightly above the Zacks Consensus Estimate of $2.76. Moreover, gross margin for fiscal 2019 is still expected to be approximately 57%. Additionally, adjusted free cash flow is anticipated to come in at least $200 million.
Moving on, Prestige Consumer is on track with its three core strategies that resulted in solid free cash flow. This, in turn, enabled the company to lower its debt to a certain extent in the quarter. Prestige Consumer is gaining on strength in leading brands that offset the impact of inventory reductions in the quarter under review. Going ahead, the company is well-positioned for long-term growth with a strong and diversified product portfolio. Also, it is striving to maintain a strong balance sheet and cost-effective capital allocation, and return high value to shareholders.
How Have Estimates Been Moving Since Then?
Fresh estimates followed a downward path over the past two months.
VGM Scores
Currently, Prestige Brands has a subpar Growth Score of D, however its Momentum Score is doing a lot better with an A. Following the exact same course, the stock was allocated a grade of A on the value side, putting it in the top quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Prestige Brands has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.